参与物
| 角色 | 名称 | HCID | 投料 |
|---|
| 反应物 | 间溴苯甲醚 | HCID 16971 | — |
| 反应物 | 4-氰基哌啶 | HCID 138223 | — |
| 试剂 | 双三甲基硅基胺基锂 | HCID 2733832 | — |
| 催化剂 | 醋酸钯 | HCID 4144353 | — |
| 催化剂 | 2,8,9-三异丁基-2,5,8,9-四氮杂-1-磷酸双向环[3.3.3]十一烷 | HCID 4571243 | — |
| 溶剂 | 甲苯 | HCID 1140 | — |
| 产物 | 1-(3-Methoxyphenyl)piperidine-4-carbonitrile | HCID 117003353 | 28.45% |
反应步骤
Reaction carried out by , work up and purification on this page. piperidine-4-carbonitrile (7.07 g, 64.16 mmol); 1-bromo-3-methoxybenzene (6.77 mL, 53.47 mmol) and diacetoxypalladium (2.401 g, 10.69 mmol) were thoroughly placed under an inert atmoshere. To this was added 2,8,9-triisobutyl-2,5,8,9-tetraaza-1-phosphabicyclo[3.3.3]undecane (0.732 g, 2.14 mmol); LITHIUM BIS(TRIMETHYLSILYL)AMIDE (123 mL, 122.97 mmol) and toluene (20 mL). The resultant mixture was stirred overnight at 100 °C (suspect that it did not need overnight. The reaction mixture was poured onto DCM (200 mL), the mixture was filtered through celite and evaporated to afford a black residue. This was suspended in EtOAc (200 mL) and water (20 mL) and filtered through a pad of silica, washing through with EtOAc (300 mL) and water (20 mL). The filtrate was evaporated to afford crude product. The crude product was purified by flash silica chromatography, elution gradient 0 to 30% EtOAc in isohexane. Pure fractions were evaporated to dryness to afford 1-(3-methoxyphenyl)piperidine-4-carbonitrile (3.29 g, 28.5 %) as a yellow oil which solidified on standing.
来源与证据
| 来源数据集 | 750 AstraZeneca ELN dataset |
|---|
| ORD ID | ord-11b483655b194597ac2e93597b6914d4 |
|---|
| 来源说明 | 750 AstraZeneca ELN dataset |
|---|